scholarly article | Q13442814 |
P2093 | author name string | Radoslav Goldman | |
Petr Pompach | |||
Julius Benicky | |||
Miloslav Sanda | |||
P2860 | cites work | Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells | Q24601584 |
Mucins in cancer: protection and control of the cell surface | Q28235006 | ||
Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search | Q28731567 | ||
SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device | Q30487950 | ||
Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum | Q36280125 | ||
A human proteome detection and quantitation project | Q37210681 | ||
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation | Q37223561 | ||
Mammalian glycosylation in immunity | Q37290930 | ||
Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. | Q37295526 | ||
Glycosylation as a strategy to improve antibody-based therapeutics | Q37402407 | ||
Metabolism, cell surface organization, and disease | Q37671886 | ||
Complex genetic regulation of protein glycosylation | Q37679726 | ||
Glycan labeling strategies and their use in identification and quantification. | Q37708129 | ||
Recent advances in the MS analysis of glycoproteins: Theoretical considerations | Q37822366 | ||
The Tn antigen-structural simplicity and biological complexity | Q37831859 | ||
The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation | Q38012171 | ||
Protein O-glycosylation analysis | Q38040264 | ||
Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines | Q39461034 | ||
Hemopexin | Q39568334 | ||
Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes | Q41201112 | ||
Intracellular distribution of haem after uptake by different receptors. Haem-haemopexin and haem-asialo-haemopexin | Q42866847 | ||
Protein glycosylation analysis by HILIC-LC-MS of Proteinase K-generated N- and O-glycopeptides | Q43133934 | ||
Micro- and macroheterogeneity of N-glycosylation yields size and charge isoforms of human sex hormone binding globulin circulating in serum | Q43736758 | ||
Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection. | Q44669026 | ||
Determination of site-specific glycan heterogeneity on glycoproteins | Q47650180 | ||
The elimination of O-linked glycans from glycoproteins under non-reducing conditions | Q72366219 | ||
Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum | Q84746102 | ||
P433 | issue | 16 | |
P304 | page(s) | 2342-2349 | |
P577 | publication date | 2013-07-24 | |
P1433 | published in | Electrophoresis | Q3050608 |
P1476 | title | LC-MS3 quantification of O-glycopeptides in human serum | |
P478 | volume | 34 |
Q39373031 | Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring |
Q31131930 | Data Independent Analysis of IgG Glycoforms in Samples of Unfractionated Human Plasma. |
Q36957711 | Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities |
Q37278723 | Increased sialylation of site specific O-glycoforms of hemopexin in liver disease. |
Q34464343 | Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease |
Q35085189 | Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease |
Q48230257 | Study of structure-dependent chromatographic behavior of glycopeptides using reversed phase nanoLC. |
Q38293204 | Targeted methods for quantitative analysis of protein glycosylation |
Search more.